Doctors Without Borders Compiles Differing Estimates of #Pharma R&D Cost per Drug | Pharmaguy's Insights Into Drug Industry News | Scoop.it

In this report, MSF compiles the different studies or reporting on R&D costs for average drug development or specific products identified in the literature, and shows to what extent estimates vary. The studies’ estimates of costs range from $30.3 million to $2.6 billion, in 2013 dollars. The most widely-cited figures of $802 million (DiMasi et al., 2003) and $2.6 billion (DiMasi et al., 2016) are based on industry-funded studies whose methodology has been widely challenged by observers, and even by Big Pharma leaders, for including sizeable, arbitrarily inflated ‘time costs’ and costs of failure. Comparing estimates of average R&D costs across time and studies is impossible because of wide variations in methods.